173 related articles for article (PubMed ID: 29901862)
1. Narrowband ultraviolet B treatment for psoriasis is highly economical and causes significant savings in cost for topical treatments.
Boswell K; Cameron H; West J; Fleming C; Ibbotson S; Dawe R; Foerster J
Br J Dermatol; 2018 Nov; 179(5):1148-1156. PubMed ID: 29901862
[TBL] [Abstract][Full Text] [Related]
2. Home Narrowband Ultraviolet B Phototherapy for Photoresponsive Skin Conditions: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(12):1-134. PubMed ID: 33240453
[TBL] [Abstract][Full Text] [Related]
3. Narrowband UVB treatment is highly effective and causes a strong reduction in the use of steroid and other creams in psoriasis patients in clinical practice.
Foerster J; Boswell K; West J; Cameron H; Fleming C; Ibbotson S; Dawe R
PLoS One; 2017; 12(8):e0181813. PubMed ID: 28771503
[TBL] [Abstract][Full Text] [Related]
4. 8-Methoxypsoralen cream plus targeted narrowband ultraviolet B for psoriasis.
Amornpinyokeit N; Asawanonda P
Photodermatol Photoimmunol Photomed; 2006 Dec; 22(6):285-9. PubMed ID: 17100735
[TBL] [Abstract][Full Text] [Related]
5. Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks.
Gambichler T; Tigges C; Scola N; Weber J; Skrygan M; Bechara FG; Altmeyer P; Kreuter A
Br J Dermatol; 2011 Jun; 164(6):1383-6. PubMed ID: 21466532
[TBL] [Abstract][Full Text] [Related]
6. Systematic review and estimated cost-efficacy of biologics compared with narrowband ultraviolet B light for the treatment of moderate to severe psoriasis and atopic dermatitis.
McCoy T; Natarelli N; Pan A; Shakhbazova A; Sivamani RK; Chambers CJ
Int J Dermatol; 2023 Aug; 62(8):986-999. PubMed ID: 37066447
[TBL] [Abstract][Full Text] [Related]
7. Phototherapy achieves significant cost savings by the delay of drug-based treatment in psoriasis.
Foerster J; Dawe R
Photodermatol Photoimmunol Photomed; 2020 Mar; 36(2):90-96. PubMed ID: 31518445
[TBL] [Abstract][Full Text] [Related]
8. Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis.
Calzavara-Pinton PG; Sala R; Arisi M; Rossi MT; Venturini M; Ortel B
Br J Dermatol; 2013 Jul; 169(1):130-6. PubMed ID: 23834117
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of a psoriasis care instruction programme with dithranol compared with UVB phototherapy and inpatient dithranol treatment.
Hartman M; Prins M; Swinkels OQ; Severens JL; De Boo T; Van Der Wilt GJ; Van De Kerkhof PC; Van Der Valk PG
Br J Dermatol; 2002 Sep; 147(3):538-44. PubMed ID: 12207597
[TBL] [Abstract][Full Text] [Related]
10. Topical 8-methoxypsoralen enhances the therapeutic results of targeted narrowband ultraviolet B phototherapy for plaque-type psoriasis.
Asawanonda P; Amornpinyokeit N; Nimnuan C
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):50-5. PubMed ID: 18181973
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
[TBL] [Abstract][Full Text] [Related]
12. Cost analysis of narrowband UVB phototherapy in psoriasis.
Langan SM; Heerey A; Barry M; Barnes L
J Am Acad Dermatol; 2004 Apr; 50(4):623-6. PubMed ID: 15034514
[TBL] [Abstract][Full Text] [Related]
13. Prior authorization for topical psoriasis treatments: is it cost-beneficial for managed care?
Balkrishnan R; Bhosle MJ; Fleischer AB; Feldman SR
J Dermatolog Treat; 2010 May; 21(3):178-84. PubMed ID: 19821787
[TBL] [Abstract][Full Text] [Related]
14. Ultraviolet B Phototherapy for Psoriasis: Review of Practical Guidelines.
Mehta D; Lim HW
Am J Clin Dermatol; 2016 Apr; 17(2):125-33. PubMed ID: 26872953
[TBL] [Abstract][Full Text] [Related]
15. Pharmacoeconomic evaluation of calcipotriol (Daivonex/Dovonex) and UVB phototherapy in the treatment of psoriasis: a Markov model for The Netherlands.
de Rie MA; de Hoop D; Jönsson L; Bakkers EJ; Sørensen M
Dermatology; 2001; 202(1):38-43. PubMed ID: 11244227
[TBL] [Abstract][Full Text] [Related]
16. Calcipotriol vs. tazarotene as combination therapy with narrowband ultraviolet B (311 nm): efficacy in patients with severe psoriasis.
Schiener R; Behrens-Williams SC; Pillekamp H; Kaskel P; Peter RU; Kerscher M
Br J Dermatol; 2000 Dec; 143(6):1275-8. PubMed ID: 11122033
[TBL] [Abstract][Full Text] [Related]
17. Comparison of clinical effects of psoriasis treatment regimens among calcipotriol alone, narrowband ultraviolet B phototherapy alone, combination of calcipotriol and narrowband ultraviolet B phototherapy once a week, and combination of calcipotriol and narrowband ultraviolet B phototherapy more than twice a week.
Takahashi H; Tsuji H; Ishida-Yamamoto A; Iizuka H
J Dermatol; 2013 Jun; 40(6):424-7. PubMed ID: 23414298
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of a novel topical cream for vitiligo and psoriasis that selectively delivers NB-UVB therapy when exposed to sunlight.
McCoy J; Goren A; Lotti T
Dermatol Ther; 2014; 27(2):117-20. PubMed ID: 23952638
[TBL] [Abstract][Full Text] [Related]
19. Calcipotriol/betamethasone ointment compared to narrow-band UVB in plaque psoriasis: first clinical and ultrasonographic study.
Polańska A; Gaura T; Bowszyc-Dmochowska M; Osmola-Mańkowska A; Olek-Hrab K; Adamski Z; Żaba R; Dańczak-Pazdrowska A
Int J Dermatol; 2019 Jan; 58(1):108-113. PubMed ID: 30070356
[TBL] [Abstract][Full Text] [Related]
20. Duration of remission period of narrowband ultraviolet B therapy on psoriasis vulgaris.
Karakawa M; Komine M; Takekoshi T; Sakurai N; Minatani Y; Tada Y; Saeki H; Tamaki K
J Dermatol; 2011 Jul; 38(7):655-60. PubMed ID: 21352300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
